Biopharma’s Coronavirus ‘Self-Isolating’: Companies Cancel Investor Meetings, Cut Back Travel
Vertex and Seattle Genetics Pull Out Of Conference
As the coronavirus spreads beyond China, biopharma companies are taking precautions, with some more wary than others.
You may also be interested in...
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
Company has instructed employees and contractors to self isolate to prevent further spread of COVID-19.
As virus impedes China’s API production and spreads to other global manufacturing centers, need for robust supply chain alternatives becomes clear.